Saudi Arabia Respiratory Care Devices Market Overview, 2031

The market for respiratory devices has developed quickly due to a rise in chronic respiratory illnesses, an aging demographic, and increased contact with environmental toxins. Technological progress like non-invasive breathing support, intelligent monitoring systems, and mobile oxygen supplies has transformed respiratory care into more effective, patient-focused approaches. These changes are strongly reflected in Saudi Arabia, where the market’s progress aligns closely with the country’s Vision 2030 healthcare improvement plan. Vision 2030 highlights the need for upgrading healthcare facilities, broadening digital health initiatives, producing medical devices locally, and enhancing access to quality care. Respiratory issues such as asthma, COPD, and sleep apnea are common in the Kingdom, influenced by high smoking levels, growing obesity rates, and regular exposure to dust storms and air pollution. Consequently, there has been a rise in the need for advanced therapeutic and monitoring respiratory devices in hospitals and home care. From a technical viewpoint, healthcare providers in Saudi Arabia are increasingly utilizing high-flow oxygen therapy systems, advanced ICU ventilators, CPAP and BiPAP machines, and connected monitoring technologies that work with electronic health records. The investments in ventilator capacity and readiness for critical care, creating a strong base of respiratory equipment. The Saudi Food and Drug Authority SFDA plays a crucial role in guiding market development. The SFDA imposes strict requirements for device registration, ensuring quality control and monitoring after products reach the market, which keeps them in line with standards like ISO and FDA guidelines. Recent changes in regulations have aimed at speeding up the approval process, supporting digital health innovations, and promoting local production in line with Vision 2030.

According to the research report, " Saudi Arabia Respiratory Devices Market Overview, 2031," published by Bonafide Research, the Saudi Arabia Respiratory Devices market is anticipated to add to more than USD 131.38 Million by 2026-31. The respiratory devices market in Saudi Arabia is one of the largest and rapidly expanding sectors within the Middle East’s medical devices industry. The market has grown consistently over the past few years and is anticipated to continue expanding at a strong mid- to high-single-digit CAGR, fueled by increasing healthcare spending, population growth, and a rise in the diagnosis of chronic respiratory ailments. In monetary terms, the market has reached a considerable size, thanks to high healthcare spending per person and significant government investment in hospital facilities. Therapeutic devices like ventilators, oxygen concentrators, and positive airway pressure devices make up a significant portion of the market value, followed by diagnostic and monitoring tools used in both urgent and long-term care. The public healthcare sector continues to be a major contributor to the market size, especially through large-scale purchases for government-run hospitals. Recent changes have opened significant prospects through public–private collaborations PPCs and healthcare privatization efforts under Vision 2030. The growth of private medical facilities, focused respiratory and sleep clinics, along with home-care service companies is fueling the need for innovative and portable respiratory equipment. Large-scale healthcare initiatives, such as new medical cities and digital hospitals, are integrating cutting-edge respiratory care systems from the beginning. Furthermore, localization efforts motivate producers to set up regional assembly, distribution, or manufacturing facilities, enhancing supply chain strength.

Saudi Arabia Respiratory Devices market by product type is divided into therapeutic devices, monitoring devices, diagnostic devices and consumables and accessories. In Saudi Arabia, the division of the respiratory devices market by product type showcases the nation’s substantial investment in healthcare, robust government purchasing, and increasing focus on sophisticated medical technologies in line with Vision 2030. Therapeutic devices lead the market due to the widespread utilization of ventilators, oxygen therapy systems, nebulizers, and positive airway pressure PAP devices in both public and private medical institutions. The COVID-19 crisis notably increased the quantity of ventilators and high-flow oxygen systems, particularly in critical care and intensive care units, leading to a lasting requirement for their upkeep and upgrades. Monitoring devices, such as pulse oximeters, capnography systems, and respiratory rate monitors, are more frequently used as hospitals transition to ongoing patient observation and data-focused care. These tools are starting to be adopted in home environments, aided by Saudi Arabia's solid digital framework. Diagnostic devices, including spirometers, sleep diagnostic systems, and equipment for pulmonary function testing, find widespread use in urban hospitals and specialty clinics, particularly for the early identification of asthma, COPD, and sleep apnea. This growth is bolstered by heightened awareness and the expansion of insurance coverage. Consumables and accessories, such as breathing circuits, filters, masks, humidifiers, and cannulas, contribute to a reliable and recurring income stream owing to high patient volumes and stringent infection control measures. Regulation by the Saudi Food and Drug Authority SFDA guarantees adherence to international safety and quality standards, shaping purchasing behaviors and promoting innovation.

Saudi Arabia Respiratory Devices market by end user is divided into hospitals, ambulatory care centers, home care settings and other user. Segmentation by end users within the respiratory devices market in Saudi Arabia reflects the changing healthcare delivery system and the Vision 2030 reform plan of the Kingdom. Hospitals are still the primary users, especially those funded by the government that deal with complex respiratory cases and critical patients. These healthcare facilities represent a significant demand for advanced ventilators, systems for oxygen delivery, and devices for continuous monitoring. Ambulatory Care Centers ACCs are growing quickly as Saudi Arabia shifts focus toward outpatient services, early diagnosis, and shorter hospital stays. ACCs are increasingly outfitted with diagnostic and monitoring respiratory equipment for asthma care, pulmonary function assessments, and evaluations of sleep disorders. The home care settings category is among the most rapidly expanding end-user segments, propelled by an aging population, a rise in chronic illnesses, and supportive policies for home care. Home oxygen therapy, CPAP machines, and portable monitoring devices are becoming more accepted due to backing from insurance and digital health services. Other end users, such as rehabilitation centers, long-term care facilities, military hospitals, and healthcare services during Hajj, add to the specialized need for portable and high-capacity respiratory devices. Collaborations between public and private sectors alongside privatization efforts are changing purchasing practices, encouraging the adoption of advanced technologies in different care environments. The end-user segmentation in Saudi Arabia signifies a gradual transition from hospital-focused respiratory care to a more diverse model that includes outpatient services and home care, boosted by significant government investment and involvement from the private sector.

"Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031



Aspects covered in this report
• Respiratory Care Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Therapeutic Devices (Inhalers,Ventilators,Positive Airway Pressure (PAP) Devices,Humidifiers,Nebulizers,Others(Oxygen Concentrators, oxygen Hood))
• Monitoring Devices (Pulse Oximeters,Gas Analyzers,Others)
• Diagnostic Devices (Spirometers,Polysomnography Devices,Peak Flow Meters,Others)
• Consumables and Accessories (Disposable Resuscitators,Breathing Circuits,Masks,Tracheostomy Tubes,Others(Nasal Cannulas))
By Disease Indication
• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other disease Indications (Respiratory Distress Syndrome, cystic Fibrosis)

By End User
• Hospitals
• Ambulatory Care Centers (ACCs)
• Home care Settings
• Other End User
"